What is GoodRx Holdings, Inc.'s D&A?

GoodRx Holdings, Inc. (GDRX) reported D&A of $21.79M in Q1 2026.

How has GoodRx Holdings, Inc.'s D&A changed year-over-year?

GoodRx Holdings, Inc.'s D&A increased by 4.2% year-over-year, from $20.91M to $21.79M.

What is the long-term trend for GoodRx Holdings, Inc.'s D&A?

Over 4 years (2021 to 2025), GoodRx Holdings, Inc.'s D&A has grown at a 25.3% compound annual growth rate (CAGR), from $34.54M to $85.22M.

Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.

GoodRx Holdings, Inc. GDRX D&A

D&A at other companies

UnitedHealth GroupUNH

$1.03B-3.0%

CVS HealthCVS

——

AmazonAMZN

——

CencoraCOR

——

GE HealthCare TechnologiesGEHC

——

Other financials

Income statement

See full

Revenue$194.0M-4.4%

Gross profit$173.9M-8.3%

Operating income$14.0M-40.1%

Net income$1.2M-89.4%

EPS (diluted)$0.00-100%

Balance sheet

See full

Cash & equivalents$235.7M-21.7%

Total debt$541.4M0.0%

Total equity$622.0M-4.9%

Total assets$2.0B+56.0%

Cash flow

See full

Operating cash flow$11.8M+25.8%

CapEx$1.1M+700%

Free cash flow$10.7M+15.4%

Valuation

See full

Market cap$911.04M-44.5%

Enterprise value$1.22B-35.4%

P/E44.3×-13.4×

P/S1.2×-0.9×

Profitability

See full

Gross margin91.8%-2.0pp

Operating margin9.9%-0.3pp

Net margin2.6%-1.0pp

FCF margin21%+2.3pp

Returns & leverage

See full

Return on equity3.2%-1.2pp

Debt / equity0.9×0.0×

Current ratio1.5×-3.8×

Where this comes from

Reported directly by GoodRx Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:DepreciationAndAmortization.

The official record: GoodRx Holdings, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about GoodRx Holdings, Inc.'s d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is GoodRx Holdings, Inc.'s D&A?: GoodRx Holdings, Inc. (GDRX) reported D&A of $21.79M in Q1 2026.
How has GoodRx Holdings, Inc.'s D&A changed year-over-year?: GoodRx Holdings, Inc.'s D&A increased by 4.2% year-over-year, from $20.91M to $21.79M.
What is the long-term trend for GoodRx Holdings, Inc.'s D&A?: Over 4 years (2021 to 2025), GoodRx Holdings, Inc.'s D&A has grown at a 25.3% compound annual growth rate (CAGR), from $34.54M to $85.22M.
What does D&A mean?: Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.